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Viruses often exert powerful selection pressures on their hosts, causing rapid evolution of host 
genes with antiviral activities. In turn, viral antagonists of these genes quickly counter-evolve, driving 
a molecular arms race between host and pathogen. A general antiviral strategy deployed by 
vertebrates involves protein kinase R (PKR). In the presence of double stranded viral RNA (dsRNA), 
PKR phosphorylates the translation initiation factor eIF2α, which inhibits protein synthesis and 
blocks virus production (see fig.). As a result of several viral strategies to evade PKR function, 
including PKR mimics and dsRNA decoys, PKR has been subjected to some of the most intense 
bouts of natural selection documented in primates (Elde et al., 2009). 
Like other viruses, cytomegaloviruses (CMVs) have had to cope with multiple host defenses, 
including the PKR pathway. CMVs have evolved PKR antagonists, such as the dsRNA binding 
protein TRS1. Evidence of strong selection on primate PKR motivated principal investigator Dr. 
Adam Geballe (Human Biology Division), staff scientist Dr. Stephanie Child and two other members 
of the Geballe Lab to investigate the contributions of CMV TRS1 to PKR evolution and, conversely, 
the effects of PKR divergence on the actions of different TRS1 proteins. 
Child et al. engineered vaccinia virus to manipulate the expression of TRS1 orthologs during 
infection of cultured primate cells. The authors found that human TRS1 (HuTRS1) inhibits PKR 
activation in human cells, but permits it when expressed in cells of Old World monkeys (rhesus and 
African green monkeys). In contrast, the rhesus monkey CMV homolog of HuTRS1 (RhTRS1) blocks 
the PKR pathway in the cells of African green monkeys, yet fails to do so when expressed in human 
or rhesus monkey cells. Despite this species specificity, Child et al. also demonstrated that both 
HuTRS1 and RhTRS1 bind to dsRNA. In primate species in which they are effective, both TRS1 
proteins also bind to PKR. The authors were initially puzzled when they found that RhTRS1 rescued 
vaccinia virus replication in African green monkey (AGM) fibroblasts but was unable to bind to 
kinase-dead AGM PKR in the yeast two-hybrid assay, which they used to study patterns of protein 
binding. This suggested that RhTRS1 and HuTRS1 might block the PKR pathway via different 
mechanisms. Digging deeper into this hunch, the researchers went on to conclusively show that 
HuTRS1 binds to inactive human PKR, whereas RhTRS1 binds to AGM PKR after it has been 
phosphorylated (see fig.). 
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These findings reveal yet another important influence on the multifaceted arms race in which PKR is 
embroiled. Counter-evolution of this critical host defense protein has diversified its binding interface, 
fundamentally altering mechanisms of PKR antagonism by the TRS1 proteins that are encoded by 
different CMV lineages. 
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Model for species specificity in modes of CMV 
TRS1 action. (a) Mixed phase/fluorescence 
photomicrograph of a CMV-eGFP plaque 
infecting a monolayer of cultured human 
fibroblasts. CMV infections are usually 
asymptomatic in the approx. 50 percent of 
adults who are seropositive for CMV in the 
United States, yet CMV can cause life-
threatening infections in newborns, transplant 
recipients and HIV-infected persons with 
advanced immunosuppression. (b) Divergent 
modes of HCMV and RhCMV antagonism of 
PKR. In the tactic used by HCMV to thwart the 
PKR pathway, TRS1 binds to dsRNA and 
dimerizes with PKR before it becomes 
activated. In contrast, RhCMV TRS1 binds to 
African green monkey PKR only after PKR has 
undergone auto-phosphorylation. Both tactics 
block the eIF2 kinase reaction, permitting 
continued viral replication. 
